Assembly Biosciences, Inc. Investment Income, Interest
Assembly Biosciences, Inc. (ASMB) reported Investment Income, Interest of $36.87 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2014-08-14
- Assembly Biosciences, Inc. investment income, interest for the quarter ending 2014-06-30 was $36.87K, a 35.17% decline year-over-year.
- Assembly Biosciences, Inc. investment income, interest for the quarter ending 2014-03-31 was $40.23K, a 12.29% decline year-over-year.
- Assembly Biosciences, Inc. investment income, interest for the quarter ending 2013-12-31 was $47.01K, a 82.77% increase year-over-year.
- Assembly Biosciences, Inc. investment income, interest for the quarter ending 2013-09-30 was $51.27K, a 243.93% increase year-over-year.
- Assembly Biosciences, Inc. investment income, interest for fiscal 2013 was $201.02K, a 208.95% increase from fiscal 2012.
- Assembly Biosciences, Inc. investment income, interest for fiscal 2012 was $65.07K, a 14.76% decline from fiscal 2011.
- Assembly Biosciences, Inc. investment income, interest for fiscal 2011 was $76.33K, a 1232.18% increase from fiscal 2010.
- Assembly Biosciences, Inc. investment income, interest for fiscal 2010 was $5.73K, a 3992.86% increase from fiscal 2009.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 69 month | Investment Income, Interest 72 month | Investment Income, Interest 75 month | Investment Income, Interest 78 month | Investment Income, Interest 81 month | Investment Income, Interest 84 month | Investment Income, Interest 87 month | Investment Income, Interest 90 month | Investment Income, Interest 93 month | Investment Income, Interest 96 month | Investment Income, Interest 99 month | Investment Income, Interest 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $36.87K 10-Q · filed 2014-08-14 | $77.11K 10-Q · filed 2014-08-14 | $124.12K derived: sum of 3 quarters · filed 2014-08-14 | $175.38K derived: sum of 4 quarters · filed 2014-08-14 | ||||||||||||
| 2014-03-31 | $40.23K 10-Q · filed 2014-05-14 | $87.25K derived: sum of 2 quarters · filed 2014-05-14 | $138.51K derived: sum of 3 quarters · filed 2014-05-14 | $195.38K derived: sum of 4 quarters · filed 2014-08-14 | $402.37K 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $47.01K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $98.28K derived: sum of 2 quarters · filed 2014-03-31 | $155.15K derived: sum of 3 quarters · filed 2014-08-14 | $201.02K 10-K · filed 2014-03-31 | $362.14K 10-K · filed 2014-03-31 | |||||||||||
| 2013-09-30 | $51.27K 10-Q · filed 2013-11-12 | $108.14K derived: sum of 2 quarters · filed 2014-08-14 | $154.01K 10-Q · filed 2013-11-12 | $179.73K derived: sum of 4 quarters · filed 2014-08-14 | $315.13K 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $56.87K 10-Q · filed 2014-08-14 | $102.74K 10-Q · filed 2014-08-14 | $128.47K derived: sum of 3 quarters · filed 2014-08-14 | $143.37K derived: sum of 4 quarters · filed 2014-08-14 | $263.86K 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | $45.87K 10-Q · filed 2014-05-14 | $71.59K derived: sum of 2 quarters · filed 2014-05-14 | $86.50K derived: sum of 3 quarters · filed 2014-05-14 | $94.76K derived: sum of 4 quarters · filed 2014-05-14 | $206.99K 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $25.72K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $40.63K derived: sum of 2 quarters · filed 2014-03-31 | $48.88K derived: sum of 3 quarters · filed 2014-03-31 | $65.07K 10-K · filed 2014-03-31 | $161.12K 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $14.91K 10-Q · filed 2013-11-12 | $23.16K derived: sum of 2 quarters · filed 2013-11-12 | $39.34K 10-Q · filed 2013-11-12 | $67.80K derived: sum of 4 quarters · filed 2013-11-12 | $135.40K 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $8.26K 10-Q · filed 2013-08-09 | $24.44K 10-Q · filed 2013-08-09 | $52.89K derived: sum of 3 quarters · filed 2013-08-09 | $81.32K derived: sum of 4 quarters · filed 2013-08-09 | $120.49K 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $16.18K 10-Q · filed 2013-05-10 | $44.63K derived: sum of 2 quarters · filed 2013-05-10 | $73.06K derived: sum of 3 quarters · filed 2013-05-10 | $79.03K derived: sum of 4 quarters · filed 2013-05-10 | $112.23K 10-Q · filed 2012-05-09 | |||||||||||
| 2011-12-31 | $28.45K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $56.88K derived: sum of 2 quarters · filed 2013-03-18 | $62.84K derived: sum of 3 quarters · filed 2013-03-18 | $76.33K 10-K · filed 2013-03-18 | $96.05K 10-K · filed 2012-03-14 | |||||||||||
| 2011-09-30 | $28.42K 10-Q · filed 2012-11-13 | $34.39K derived: sum of 2 quarters · filed 2012-11-13 | $47.88K 10-Q · filed 2012-11-13 | $51.91K derived: sum of 4 quarters · filed 2013-03-18 | $67.60K 10-Q/A · filed 2011-11-18 | |||||||||||
| 2011-06-30 | $5.97K 10-Q · filed 2012-08-09 | $19.46K 10-Q · filed 2012-08-09 | $23.48K derived: sum of 3 quarters · filed 2013-03-18 | $23.86K derived: sum of 4 quarters · filed 2013-03-18 | $39.18K 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | $13.49K 10-Q · filed 2012-05-09 | $17.52K derived: sum of 2 quarters · filed 2013-03-18 | $17.89K derived: sum of 3 quarters · filed 2013-03-18 | $19.21K derived: sum of 4 quarters · filed 2013-03-18 | ||||||||||||
| 2010-12-31 | $4.03K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $4.40K derived: sum of 2 quarters · filed 2013-03-18 | $5.72K derived: sum of 3 quarters · filed 2013-03-18 | $5.73K 10-K · filed 2013-03-18 | ||||||||||||
| 2010-09-30 | $378.00 10-Q/A · filed 2011-11-18 | $1.70K derived: sum of 2 quarters · filed 2011-11-18 | $1.71K 10-Q/A · filed 2011-11-18 | |||||||||||||
| 2010-06-30 | $1.32K 10-Q · filed 2011-08-15 | $1.33K 10-Q · filed 2011-08-15 | ||||||||||||||
| 2009-12-31 | $140.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |